[ad_1] Check out the companies making headlines before the bell. Tesla — The electric vehicle maker rose nearly 1%, adding…
Browsing: Iovance
[ad_1] hapabapa Iovance Biotherapeutics (NASDAQ:IOVA) lost ~26% pre-market Tuesday after the FDA placed its Phase 2 IOV-LUN-202 trial for experimental…
[ad_1] Sundry Photography/iStock Editorial via Getty Images Stock futures rose in the early hours of Friday, building off a 400-point…
[ad_1] Shares of microcap Better Therapeutics Inc. BTTX, -19.64% surged 52% ahead of a conference call scheduled Tuesday morning after…
[ad_1] Underwriters are granted a 30-day option to purchase up to 3 million additional shares of common stock at the…
[ad_1] An analyst from Stifel maintained Iovance Biotherapeutics (NASDAQ: ) at ‘buy’ with a price target of $27.00 from a…
[ad_1] Oli Scarff Barclays says it has chosen Biomea Fusion (NASDAQ:BMEA), Replimune (NASDAQ:REPL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Iovance Biotherapeutics (NASDAQ:IOVA)…
[ad_1] Iovance up 15% on FDA acceptance of lifileucel application for melanoma [ad_2] Source link
[ad_1] Iovance up 13% on completing Biologics License Application submission for lifileucel [ad_2] Source link
[ad_1] By Sam Boughedda Iovance Biotherapeutics (NASDAQ:) was raised to Overweight from Neutral by Piper Sandler analysts on Friday, who…